2/22/2008

The European Medicines Agency has endorsed the approval of Prepandrix, the world's first pre-pandemic bird flu vaccine, developed by GlaxoSmithKline PLC. A spokesman for Glaxo said that the company intends to seek FDA approval by the end of the year.

Related Summaries